Online Tai Chi Versus Digital CBT-I for Chronic Insomnia

October 21, 2026 updated by: jinze wu, The Third Xiangya Hospital of Central South University

Efficacy of Online Tai Chi Versus Digital Cognitive Behavioral Therapy for Insomnia in Adults With Chronic Insomnia Disorder: A Multicenter Pragmatic Randomized Controlled Noninferiority Trial

This multicenter randomized controlled trial will compare online Tai Chi (OTC) with digital cognitive behavioral therapy for insomnia (dCBT-I) in adults with chronic insomnia disorder. A total of 172 participants aged 18 to 65 years will be randomly assigned in a 1:1 ratio to receive either a 6-week standardized online Tai Chi intervention or a 6-week structured dCBT-I intervention. Both groups will receive the same standardized sleep hygiene education. The primary objective is to determine whether online Tai Chi is noninferior to dCBT-I in improving insomnia severity at Week 6, as measured by change in the Insomnia Severity Index (ISI) from baseline. Participants will be followed through Week 30. Approximately 120 participants will additionally participate in an actigraphy substudy with 7-day assessments at baseline, Week 6, and Week 30.

Study Overview

Detailed Description

This is a three-center, pragmatic, open-label, parallel-group randomized controlled noninferiority trial. Eligible participants will complete a 7-day run-in period and will then be randomized 1:1 to online Tai Chi or dCBT-I, stratified by study center. Both groups will receive the same 15-20 minute standardized sleep hygiene education. The online Tai Chi group will complete a standardized 6-week program, with at least three sessions per week and three to five sessions recommended, approximately 30-45 minutes per session. The dCBT-I group will complete a structured 6-week digital program consisting of one core module per week, behavioral practice, and sleep diaries. The primary efficacy assessment will occur at Week 6. After Week 6, no protocol-mandated maintenance treatment will be provided. The final scheduled assessment will occur at Week 30. The protocol currently uses a proposed noninferiority margin of 3 ISI points for sample-size planning. The final margin will be locked before the first participant is randomized. The intention-to-treat population will be used for the primary analysis, with a per-protocol analysis as a key supportive analysis.

Study Type

Interventional

Enrollment (Estimated)

172

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Hunan
      • Changsha, Hunan, China
        • The Third Xiangya Hospital, Central South University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 18 to 65 years, inclusive.
  2. Meet DSM-5 diagnostic criteria for chronic insomnia disorder, confirmed by a trained study physician.
  3. ISI ≥12 at screening and at the end of the 7-day run-in period, with an absolute difference <4 points.
  4. Complete at least 5 valid sleep diary days during the run-in period.
  5. Have a suitable smart device and stable internet connection and be able to complete study procedures.
  6. Provide written informed consent.
  7. Be willing to accept randomized assignment, complete the 6-week intervention, and participate through Week 30.

Exclusion Criteria:

  1. Another untreated or inadequately controlled sleep disorder likely to affect outcomes or safety.
  2. Regular night-shift/rotating shift work or another substantially disruptive sleep-wake schedule.
  3. Severe or unstable medical disease, clinically significant chronic pain interfering with sleep, or physical/motor impairment preventing safe participation.
  4. Clinically significant cognitive impairment preventing independent informed consent or reliable participation.
  5. Acute or unstable severe psychiatric illness, clinically significant suicide risk, or active substance use disorder requiring priority treatment.
  6. A condition making sleep restriction/compression unsuitable, including uncontrolled epilepsy, current mania/hypomania or clinically significant triggering risk, hazardous daytime sleepiness, or an inadequately mitigated safety-sensitive occupation.
  7. Regular participation during the previous 3 months in a highly similar mind-body training program likely to affect treatment evaluation.
  8. Current systematic CBT-I, or prior CBT-I with continued regular implementation of core therapeutic strategies likely to affect treatment evaluation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Online Tai Chi

Participants will receive standardized sleep hygiene education followed by a standardized 6-week online Tai Chi program. Participants will practice at least three times per week, preferably three to five times per week, for approximately 30-45 minutes per session. Each session includes warm-up, core Tai Chi movements, and cool-down. All centers will use the same standardized training materials and procedures.

Active Comparator: Digital Cognitive Behavioral Therapy for Insomnia

Participants will receive standardized sleep hygiene education followed by a structured 6-week digital CBT-I program. Week 1 covers insomnia-maintaining factors and stimulus control; Week 2 sleep-time management; Week 3 review of behavioral prescriptions; Week 4 cognitive restructuring; Week 5 relaxation and arousal management; and Week 6 integration of skills and relapse prevention. Daily sleep diaries and behavioral practice are incorporated into treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Insomnia Severity Index Score From Baseline to Week 6
Time Frame: Baseline (end of the 7-day run-in period) to Week 6

The Insomnia Severity Index (ISI) is a 7-item self-report measure with a total score ranging from 0 to 28; higher scores indicate greater insomnia severity. The primary outcome is Week 6 ISI minus baseline ISI. A negative value indicates improvement.

Baseline (end of the 7-day run-in period) to Week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in ISI Score From Baseline to Week 30
Time Frame: Baseline to Week 30

The Insomnia Severity Index (ISI) is a 7-item self-report measure with a total score ranging from 0 to 28; higher scores indicate greater insomnia severity. The primary outcome is Week 6 ISI minus baseline ISI. A negative value indicates improvement.

Baseline to Week 30
Change in ISI Score From Baseline to Week 3
Time Frame: Baseline to Week 3

The Insomnia Severity Index (ISI) is a 7-item self-report measure with a total score ranging from 0 to 28; higher scores indicate greater insomnia severity. The primary outcome is Week 6 ISI minus baseline ISI. A negative value indicates improvement.

Baseline to Week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 10, 2026

Primary Completion (Estimated)

October 10, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

September 26, 2026

First Submitted That Met QC Criteria

September 26, 2026

First Posted (Actual)

October 2, 2026

Study Record Updates

Last Update Posted (Actual)

October 26, 2026

Last Update Submitted That Met QC Criteria

October 21, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • OTC-dCBTI-INSOMNIA-2026-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe